Immucor Announces Fiscal First Quarter Results; EPS $.30


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for its fiscal 2011 first quarter ended August 31, 2010.Highlights--Revenue for the first quarter of fiscal 2011 was $83.6 million, up 1% from $83.1 million in the prior year quarter. --Gross margin was 71.3% in the quarter compared with 71.9% in the prior year quarter. --Diluted earnings per share totaled $0.30 in the quarter compared with $0.30 for the same period last year. --Cash flow from operations for the quarter ended August 31, 2010 was $28.9 million compared with $24.5 million in the prior year. --Worldwide instrument orders for the first quarter of fiscal year 2011 were 26 Echo® orders and 18 NEO™ orders. NEO is the Company's new high volume instrument that is currently in the process of being launched worldwide.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: EarningsNewsHealth CareHealth Care Supplies